申请人:Merck & Co., Inc.
公开号:US04085125A1
公开(公告)日:1978-04-18
This invention relates to 9-thia-, 9-oxothia-, and 9-dioxothia-11,12-seco-prostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful for the treatment of skin diseases such as psoriasis, for the prevention of thrombus formation, in stimulating the production of growth hormone in intact animals, and as regulators of the immune response.
本发明涉及9-硫代、9-氧代硫代和9-二氧代硫代-11,12-去甲环孢素类前列腺素及其制造工艺。这些化合物具有类前列腺素的生物活性,特别适用于治疗皮肤病如银屑病、预防血栓形成、促进完整动物生长激素的产生以及作为免疫应答的调节剂。